Skip to search formSkip to main contentSkip to account menu

dinaline

Known as: 4-aminobenzoyl-1,2-phenylenediamine, Benzamide, 4-amino-N-(2-aminophenyl)-, 2',4-Diaminobenzanilide 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (3)

GOE1734Goe 1734NSC 328786

Broader (1)

Phenylenediamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Riproximin Is A New Plat Lectin With Antineoplastic Activity Aganist In Rat Pancreatic Cancer.
Purpose: Pancreatic ductal adenocarcinoma (PDAC) has one of the worst prognoses of all malignancies. At time of diagnosis, 80% of… 
2005
2005
Combination treatment based on metabolic effects of dinaline
The human colon carcinoma cell line SW 707 was exposed for up to 72 h to the new antineoplastic agent 4-amino-N-(2′-aminophenyl… 
2004
2004
Preclinical pharmacokinetic, antitumor and toxicity studies with CL-994 (N-acetyldinaline)
CI-994, a substituted benzamide derivative, is a compound that showed solid tumor selectivity for a variety of solid tumor models… 
2004
2004
In vitro and in vivo effects of acetyldinaline on murine megakaryocytopoiesis
PurposeAcetyldinaline (CI-994) has shown preclinical efficacy in vitro and in vivo against solid tumor and leukemia cell lines… 
1997
1997
Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline).
CI-994, a substituted benzamide derivative, is a compound that showed solid tumor selectivity for a variety of solid tumor models… 
1995
1995
Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro.
The human colon carcinoma cell line SW707 was incubated with different concentrations (7 microM - 540 microM) of the novel… 
1991
1991
On the long-term toxic risk of dinaline.
1991
1991
Strategies of reducing the carcinogenic risk of cytostatic agents on the basis of bioassay evaluation.
This article described strategies that can be used to reduce the carcinogenic risk of cytostatic chemotherapy and summarizes our… 
1988
1988
Dinaline: a new oral drug against leukemia? Preclinical studies in a relevant rat model for human acute myelocytic leukemia (BNML).
The efficacy and toxicity of Dinaline (GOE 1734; PD 104 208; NSC 328786; 4-amino-N-(2'-aminophenyl)benzamide) was evaluated in… 
1985
1985
Synthesis, toxicity, and therapeutic efficacy of 4-amino-N-(2'-aminophenyl)-benzamide: a new compound preferentially active in slowly growing tumors.
The present paper describes 4-amino-N-(2'-aminophenyl)benzamide (GOE1734) with regard to synthesis; toxicity in mice, rats, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)